Medical writing consulting and drug dossier development support services
Ended Purchase Order Awarded Last action
- Contract number
- 75N95020P00589
- Awardee
-
CCS Associates, Inc. UEI VCNRS52G5PG7
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $144,986
Award facts
- Opportunity
-
- Medical Writing Consultant Support Services Solicitation · NIHNINDSCSS20005290 · Posted Aug 17, 2020
- Medical Writing Consultant Support Services Award Notice · Posted Sep 11, 2020
- Contract value 33% obligated
-
- $142,947.38 Current, with exercised options
- $439,593.88 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- Total Small Business
- Competition
- Competed under SAP · 5 offers Simplified Acquisition
- Pricing
- Labor Hours
- Place of performance
- San Jose, CA 95110, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$20,217 | |
| Exercise an Option | $28,598 | |
| Exercise an Option | $6,941 | |
| Exercise an Option | $7,150 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $82,080 | |
| Original award | $40,434 |
About this award
The National Institute on Drug Abuse awarded a purchase order to CCS Associates, Inc., a woman-owned small business, on September 11, 2020, for $439,593.88 under a Total Small Business set-aside. The order supports medical writing consulting and drug dossier development services with ultimate completion on September 13, 2023. Work is performed in San Jose, California. The solicitation, posted August 17, 2020 with an August 24 deadline, sought regulatory document preparation and medical writing support for NIH neuroscience research programs including the Blueprint Neurotherapeutics Program and Early Phase Pain Investigation Clinical Network. Base period runs one year from September 14, 2020 with two optional one-year extensions; services required minimum 20 hours annually on a part-time basis. Service Contract Inventory data shows declining labor footprint: FY2021 invoiced $59 thousand (0.2 FTEs, 437 hours); FY2022 invoiced $49 thousand (0.2 FTEs, 350 hours); FY2023 invoiced $33 thousand (0.1 FTEs, 229 hours). Derived government-paid rates rose from $134.78 per hour in FY2021 to $142.99 per hour in FY2023. The prime self-performed all reported labor; no subcontractors engaged.
Quick answers
Who was awarded contract 75N95020P00589?
75N95020P00589 was awarded to CCS Associates, Inc. by National Institute on Drug Abuse (National Institutes of Health) on September 11, 2020.
How much is contract 75N95020P00589 worth?
The government has obligated $144,986 on 75N95020P00589. Its current value, with exercised options, is $142,947. Its potential value, with all options, is $439,594.
Was contract 75N95020P00589 competed?
The extent of competition for 75N95020P00589 was competed under sap. The government received 5 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award